Accetto Utilizziamo cookies per migliorare il nostro servizio e realizzare statistiche. Questa funzione puó essere disattivata cambiando la configurazione del browser. Continuando a navigare senza modificare questi parametri, consideriamo che l’uso di cookies sia accettato
5-Fluoro-3-hydroxy-2-methylbenzoic acid 1 was synthesized from 5-fluoro-2-methylbenzoic acid by nitration, reduction, diazotization and hydrolysis. Another methylcarbamoyl-substituted benzylamine 12 was synthesized from 5-fluoro-2-methylbenzoic acid via the sequential bromination,azido replacement and the reduction.
Eiji Takashiro,; Ichiro Hayakawa,; Tamayo Nitta,; Atsushi Kasuya,; Shuichi Miyamoto,; Yuji Ozawa,; Ryuichi Yagi,; Ikue Yamamoto,; Takahiro Shibayama,; Akihiko Nakagawa,; Yuichiro Yabe. Structure-activity relationship of HIV-1 protease inhibitors containing α-hydroxy-β-amino acids. Detailed study of P1 site. Bioorganic & Medicinal Chemistry. 1999, 7(9),2063-2072.
Xing Fana,; Feng-Hua Zhanga,; Rasha I. Al-Safi,; Li-Fan Zenga,; Yumna Shabaik,; Bikash Debnath,; Tino W. Sanchez,; Srinivas Odde,; Nouri Neamati,; Ya-Qiu Long. Design of HIV-1 integrase inhibitors targeting the catalytic domain as well as its interaction with LEDGF/p75: A scaffold hopping approach using salicylate and catechol groups. Bioorganic & Medicinal Chemistry. 2011, 19(16), 4935-4952.
Dichiarazioni di rischio (UE): H315-H319-H335
Causes skin irritation. Causes serious eye irritation. May cause respiratory irritation.
Dichiarazioni precauzionali: P280g-P305+P351+P338
Wear protective gloves. IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.